Viewing StudyNCT04466891

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 2:54 PM
Last Modification Date: 2024-10-26 @ 1:39 PM
Study NCT ID: NCT04466891
Status: COMPLETED
Last Update Posted: 2024-06-27
First Post: 2020-07-06
Brief Title: A Study of ZW25 Zanidatamab in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
Sponsor: Jazz Pharmaceuticals
Organization: Jazz Pharmaceuticals
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
HER2-amplified Biliary Tract Cancers
Keywords:
Name View
HER2 View
Bispecific antibody View
Biparatopic antibody View
Immunotherapy View
Biliary Tract Cancer View
Intra-hepatic cholangiocarcinoma View
Extra-hepatic cholangiocarcinoma View
Gallbladder cancer View
JZP598 View